Royalty Pharma Is A Leading Company In The Life Sciences Sectorfounded In 1996 And Headquartered In New York City And Dublinirelandthe Company Specializes In Biopharmaceutical Royalty Acquisitionsproviding Innovative Funding Solutions To Support The Development Of Late Stage And Marketed Drugsby Acquiring Existing Royalties And Co Funding Clinical Trialsroyalty Pharma Helps Unlock Value From Intellectual Propertyfacilitating The Advancement Of New Treatments The Company Partners With A Diverse Range Of Entitiesincluding Academic Institutionsresearch Hospitalsand Pharmaceutical Companieswith A Significant Market Share In Biopharmaceutical Royalty Transactionsroyalty Pharma Has Provided Over $20 Billion In Funding For Royalty Acquisitions Since Its Inceptionled By Ceo Pablo Legorretathe Company Operates With A Smallexpert Teammaking A Substantial Impact On The Life Sciences Industry Through Its Unique Funding Models And Collaborations
